JSP 545 (Digoxin 250 mcg (0.25 mg))

Pill imprint JSP 545 has been identified as Digoxin 250 mcg (0.25 mg).

Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 250 mcg (0.25 mg) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for JSP 545

Digoxin 250 mcg (0.25 mg) JSP 545
Digoxin 250 mcg (0.25 mg) JSP 545  Front
Digoxin 250 mcg (0.25 mg) JSP 545  Back
Digoxin 250 mcg (0.25 mg) JSP 545
Digoxin
Imprint:
JSP 545
Strength:
250 mcg (0.25 mg)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Group V antiarrhythmics
Inotropic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lannett Company, Inc.
National Drug Code (NDC):
00527-1325
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0990 Amerisource Health Services
66336-0607 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)